scholarly journals Adjunct Therapy in Type 1 Diabetes: A Survey to Uncover Unmet Needs and Patient Preferences Beyond HbA1c Measures

2019 ◽  
Vol 21 (6) ◽  
pp. 336-343 ◽  
Author(s):  
Jeremy H. Pettus ◽  
Jake A. Kushner ◽  
Virginia Valentine ◽  
Richard Wood ◽  
Christianne Pang ◽  
...  
Keyword(s):  
Type 1 Diabetes ◽  
Patient Preferences ◽  
Unmet Needs ◽  
Adjunct Therapy

Increased Time-in-Range with Sotagliflozin as Adjunct Therapy to Insulin in Adults with Type 1 Diabetes as Demonstrated by 24-Week Continuous Glucose Monitoring (inTandem1, inTandem2)

Diabetes ◽  
2018 ◽  
Vol 67 (Supplement 1) ◽  
pp. 1179-P ◽  
Author(s):  
THOMAS DANNE ◽  
BERTRAND CARIOU ◽  
JOHN B. BUSE ◽  
SATISH K. GARG ◽  
JULIO ROSENSTOCK ◽  
...  
Keyword(s):  
Type 1 Diabetes ◽  
Continuous Glucose Monitoring ◽  
Glucose Monitoring ◽  
Adjunct Therapy ◽  
Time In Range

Fifty-Two-Week Efficacy and Safety of Sotagliflozin, a Dual SGLT1 and SGLT2 Inhibitor, as Adjunct Therapy to Insulin in Adults with Type 1 Diabetes (inTandem1)

Diabetes ◽  
2018 ◽  
Vol 67 (Supplement 1) ◽  
pp. 212-OR ◽  
Author(s):  
JOHN B. BUSE ◽  
SATISH K. GARG ◽  
JULIO ROSENSTOCK ◽  
TIMOTHY S. BAILEY ◽  
PHILLIP L. BANKS ◽  
...  
Keyword(s):  
Type 1 Diabetes ◽  
Sglt2 Inhibitor ◽  
Efficacy And Safety ◽  
Adjunct Therapy

scholarly journals Dapagliflozin as an Adjunct Therapy to Insulin in Patients with Type 1 Diabetes Mellitus: Efficacy and Safety of this Combination

2021 ◽  
Vol 1 (1) ◽  
pp. 12
Author(s):  
Johan H Jendle ◽  
Francisco J Ampudia-Blasco ◽  
Martin Füchtenbusch ◽  
Paolo Pozzilli ◽  
◽  
...  
Keyword(s):  
Diabetes Mellitus ◽  
Type 1 Diabetes ◽  
Type 1 Diabetes Mellitus ◽  
Efficacy And Safety ◽  
Adjunct Therapy

scholarly journals Dapagliflozin as an Adjunct Therapy to Insulin in Patients with Type 1 Diabetes Mellitus: Efficacy and Safety of this Combination

2021 ◽  
Vol 1 (1) ◽  
pp. 12
Author(s):  
Johan H Jendle ◽  
Francisco J Ampudia-Blasco ◽  
Martin Füchtenbusch ◽  
Paolo Pozzilli ◽  
◽  
...  
Keyword(s):  
Diabetes Mellitus ◽  
Type 1 Diabetes ◽  
Type 1 Diabetes Mellitus ◽  
Efficacy And Safety ◽  
Adjunct Therapy

PDB40 Eliciting Patient Preferences for Continuous Glucose Monitoring Devices in Type 1 Diabetes

2021 ◽  
Vol 24 ◽  
pp. S85
Author(s):  
K. Hannah ◽  
R. Lich ◽  
K. Nair ◽  
H.D. Anderson ◽  
S. Ellis ◽  
...  
Keyword(s):  
Type 1 Diabetes ◽  
Continuous Glucose Monitoring ◽  
Patient Preferences ◽  
Glucose Monitoring ◽  
Monitoring Devices

1198-P: Sex Hormone Binding Globulin (SHBG) as an Indicator of Reduced Insulin Sensitivity in Type 1 Diabetes (T1D) Adults and a Potential Tool to Guide Adjunct Therapy

Diabetes ◽  
2021 ◽  
Vol 70 (Supplement 1) ◽  
pp. 1198-P
Author(s):  
ANDRZEJ S. JANUSZEWSKI ◽  
WAYNE RANKIN ◽  
DAVID N. O'NEAL ◽  
GARY A. WITTERT ◽  
ALICIA JENKINS
Keyword(s):  
Type 1 Diabetes ◽  
Insulin Sensitivity ◽  
Sex Hormone ◽  
Sex Hormone Binding Globulin ◽  
Hormone Binding ◽  
Adjunct Therapy ◽  
Potential Tool

Potential role of non-insulin adjunct therapy in Type 1 diabetes

2013 ◽  
Vol 30 (2) ◽  
pp. 179-188 ◽  
Author(s):  
P. George ◽  
R. J. McCrimmon
Keyword(s):  
Type 1 Diabetes ◽  
Potential Role ◽  
Adjunct Therapy
Sign in / Sign up

Export Citation Format

Share Document